Patents by Inventor Amalie Kai BENTZEN

Amalie Kai BENTZEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240272147
    Abstract: The present invention relates to detection molecules comprising at least one binding molecule, at least one linker and at least one label, and detection methods making use of same. The invention provides a high-throughput method for detection, isolation and/or identification of specific entities or cells.
    Type: Application
    Filed: April 20, 2023
    Publication date: August 15, 2024
    Inventors: Henrik PEDERSEN, Søren JAKOBSEN, Sine Reker HADRUP, Amalie Kai BENTZEN, Kristoffer Haurum JOHANSEN
  • Patent number: 11668705
    Abstract: The present invention relates to detection molecules comprising at least one binding molecule, at least one linker and at least one label, and detection methods making use of same. The invention provides a high-throughput method for detection, isolation and/or identification of specific entities or cells.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: June 6, 2023
    Assignees: Immudex Aps, Herlev Hospital
    Inventors: Henrik Pedersen, Søren Jakobsen, Sine Reker Hadrup, Amalie Kai Bentzen, Kristoffer Haurum Johansen
  • Patent number: 11585806
    Abstract: The present invention relates to detection molecules comprising at least one binding molecule, at least one linker and at least one label, and detection methods making use of same. The invention provides a high-throughput method for detection, isolation and/or identification of specific entities or cells.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: February 21, 2023
    Assignees: Immudex ApS, Herlev Hospital
    Inventors: Henrik Pedersen, Søren Jakobsen, Sine Reker Hadrup, Amalie Kai Bentzen, Kristoffer Haurum Johansen
  • Publication number: 20220341921
    Abstract: The present invention relates to detection molecules comprising at least one binding molecule, at least one linker and at least one label, and detection methods making use of same. The invention provides a high-throughput method for detection, isolation and/or identification of specific entities or cells.
    Type: Application
    Filed: June 30, 2022
    Publication date: October 27, 2022
    Inventors: Henrik PEDERSEN, Søren JAKOBSEN, Sine Reker HADRUP, Amalie Kai BENTZEN, Kristoffer Haurum JOHANSEN
  • Patent number: 11402373
    Abstract: The present invention relates to detection molecules comprising at least one binding molecule, at least one linker and at least one label, and detection methods making use of same. The invention provides a high-throughput method for detection, isolation and/or identification of specific entities or cells.
    Type: Grant
    Filed: February 10, 2022
    Date of Patent: August 2, 2022
    Assignees: Immudex ApS, Herlev Hospital
    Inventors: Henrik Pedersen, Søren Jakobsen, Sine Reker Hadrup, Amalie Kai Bentzen, Kristoffer Haurum Johansen
  • Publication number: 20220205984
    Abstract: The present invention relates to detection molecules comprising at least one binding molecule, at least one linker and at least one label, and detection methods making use of same. The invention provides a high-throughput method for detection, isolation and/or identification of specific entities or cells.
    Type: Application
    Filed: February 10, 2022
    Publication date: June 30, 2022
    Inventors: Henrik PEDERSEN, Søren JAKOBSEN, Sine Reker HADRUP, Amalie Kai BENTZEN, Kristoffer Haurum JOHANSEN
  • Publication number: 20180180601
    Abstract: The present invention relates to detection molecules comprising at least one binding molecule, at least one linker and at least one label, and detection methods making use of same. The invention provides a high-throughput method for detection, isolation and/or identification of specific entities or cells.
    Type: Application
    Filed: June 15, 2015
    Publication date: June 28, 2018
    Inventors: Henrik PEDERSEN, Søren JAKOBSEN, Sine Reker HADRUP, Amalie Kai BENTZEN, Kristoffer Haurum JOHANSEN
  • Publication number: 20170343545
    Abstract: The present invention describes the use of nucleic acid barcodes as specific labels for MHC multimers to determine the antigen responsiveness in biological samples. After cellular selection the barcode sequence will be revealed by sequencing. This technology allows for detection of multiple (potentially >1000) different antigen-specific cells in a single sample. The technology can be used for T-cell epitope mapping, immune-recognition discovery, diagnostics tests and measuring immune reactivity after vaccination or immune-related therapies.
    Type: Application
    Filed: June 8, 2015
    Publication date: November 30, 2017
    Inventors: Sine Reker HADRUP, Henrik PEDERSEN, Søren JAKOBSEN, Amalie Kai BENTZEN